Landmark discovery in rapid spread of PRL-3 oncoprotein associated aggressive cancers
Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have made a landmark discovery in the battle against the rapid spread of aggressive cancers associated with PRL-3 oncoprotein.